Re:NewCell AB (publ)

DB:6QP Stock Report

Market Cap: €19.5m

Re:NewCell Valuation

Is 6QP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6QP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 6QP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 6QP's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6QP?

Key metric: As 6QP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6QP. This is calculated by dividing 6QP's market cap by their current revenue.
What is 6QP's PS Ratio?
PS Ratio1.1x
SalesSEK 205.18m
Market CapSEK 219.03m

Price to Sales Ratio vs Peers

How does 6QP's PS Ratio compare to its peers?

The above table shows the PS ratio for 6QP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
IBU IBU-tec advanced materials
0.7x19.2%€33.3m
NSAK OTI Greentech
0.03xn/a€571.0k
SIM0 SIMONA
0.6xn/a€357.0m
PPK PPK Group
1.4xn/aAU$39.4m
6QP Re:NewCell
1.1x83.0%€219.0m

Price-To-Sales vs Peers: 6QP is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (4x).

Price to Sales Ratio vs Industry

How does 6QP's PS Ratio compare vs other companies in the DE Chemicals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
2HRA H&R GmbH KGaA
0.1x3.0%US$132.56m
NSAK OTI Greentech
0.03xn/aUS$594.62k
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
6QP 1.1xIndustry Avg. 1.0xNo. of Companies4PS00.40.81.21.62+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 6QP is good value based on its Price-To-Sales Ratio (1.1x) compared to the European Chemicals industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is 6QP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6QP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: 6QP is expensive based on its Price-To-Sales Ratio (1.1x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6QP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€3.50
0%
75.0%€6.12€0.87n/a2
Nov ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
Oct ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
Sep ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
Aug ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
Jul ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
Jun ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
May ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
Apr ’25n/a
€3.50
0%
75.0%€6.12€0.87n/a2
Mar ’25€0.45
€3.50
+668.9%
75.0%€6.12€0.87n/a2
Feb ’25€0.78
€3.50
+346.0%
75.0%€6.12€0.87n/a2
Jan ’25€0.70
€3.50
+397.1%
75.0%€6.12€0.87n/a2
Dec ’24€0.66
€3.50
+433.9%
75.0%€6.12€0.87n/a2
Nov ’24€0.97
€6.97
+620.9%
81.5%€12.66€1.29n/a2
Oct ’24€5.71
€13.97
+144.7%
14.4%€16.80€12.35n/a3
Sep ’24€7.31
€13.97
+91.1%
14.4%€16.80€12.35n/a3
Aug ’24€6.60
€17.90
+171.3%
24.8%€23.60€12.76n/a3
Jul ’24€6.52
€16.79
+157.6%
31.2%€23.11€10.28n/a3
Jun ’24€6.42
€17.37
+170.6%
31.2%€23.91€10.64n/a3
May ’24€7.01
€17.99
+156.8%
34.7%€25.79€10.51n/a3
Apr ’24€7.17
€20.26
+182.6%
30.6%€26.41€11.76n/a3
Mar ’24€8.21
€20.26
+146.8%
30.6%€26.41€11.76€0.453
Feb ’24€8.34
€16.40
+96.7%
38.1%€22.65€10.15€0.782
Jan ’24€6.53
€16.40
+151.1%
38.1%€22.65€10.15€0.702

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

UBE

JP¥237.9b

Engages in the chemicals, construction materials, and machinery businesses in Japan, North America, Europe, Africa, the Middle East, Thailand, India, Latin America, and internationally.

UBE

JP¥15.00

7D

6.4%

1Y

5.6%

Ecora Resources

UK£162.5m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

HGR

UK£0.76

7D

-1.4%

1Y

-29.4%

Stanmore Resources

AU$2.8b

Engages in the exploration, development, production, and sale of metallurgical coal in Australia.

S0D

AU$1.91

7D

2.1%

1Y

-15.5%